“The current circumstance has exposed some structural weaknesses inside the EU’s medicines offer chain plus a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She encouraged that provide chain challenges be dealt with in an EU pharmaceutical method expected to be launched by th